{"id":"W4308551699","doi":"10.1016/j.cgh.2022.10.032","title":"GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus","year":2022,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"Medical Research Council; National Institute for Health and Care Research; GlaxoSmithKline","keywords":"Medicine; Dose-ranging study; Randomized controlled trial; Gastroenterology; Biliary tract; Internal medicine; Pathology; Double blind; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001602802,0.001469911,0.002480054,0.0005262826,0.000331283,0.0007619888,0.0009052822,0.001397648,0.005727373],"category_scores_gemma":[0.001187054,0.0006355818,0.001150465,0.000362509,0.0009443572,0.0008115302,0.0004833445,0.002441411,0.0009659601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005393809,"about_ca_system_score_gemma":0.0009235439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004875861,"about_ca_topic_score_gemma":0.001493852,"domain_scores_codex":[0.9993852,0.0003396074,0.00003261013,0.00008523073,0.0000527169,0.0001046479],"domain_scores_gemma":[0.9995096,0.0001051837,0.0001284957,0.00004044017,0.00003259851,0.0001837178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.942728,0.01398548,0.001336124,0.0008272754,0.0006769243,0.00009229434,0.00007974645,0.000450543,0.0088435,0.0001156454,0.001369656,0.02949496],"study_design_scores_gemma":[0.9199809,0.07670716,0.001982681,0.00001715268,0.0001454538,0.00004888274,0.00001546937,0.0002383335,0.0003737014,0.00004409399,0.0004361962,0.00001003743],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894423,0.002822414,0.000459869,0.0007461759,0.0002218103,0.003970738,0.0008124067,0.0002449895,0.001279166],"genre_scores_gemma":[0.9827001,0.002088662,0.002329358,0.001878501,0.0003380669,0.006458227,0.001243334,0.00004641928,0.002917346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005727373,"threshold_uncertainty_score":0.01915997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01407075095743054,"score_gpt":0.2959649216142333,"score_spread":0.2818941706568028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}